- Home
- Publications
- Publication Search
- Publication Details
Title
NF-κB in colorectal cancer
Authors
Keywords
NF-κB, Colorectal cancer, Colitis-associated cancer, Inflammation, Targeted therapy
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 91, Issue 9, Pages 1029-1037
Publisher
Springer Nature
Online
2013-05-01
DOI
10.1007/s00109-013-1045-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p53-Independent Roles of MDM2 in NF-κB Signaling: Implications for Cancer Therapy, Wound Healing, and Autoimmune Diseases
- (2015) Dana Thomasova et al. NEOPLASIA
- Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways
- (2013) Mehdi Shakibaei et al. PLoS One
- CARMA3 is overexpressed in colon cancer and regulates NF-κB activity and cyclin D1 expression
- (2012) Zhifeng Miao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of p53 in Enterocytes Generates an Inflammatory Microenvironment Enabling Invasion and Lymph Node Metastasis of Carcinogen-Induced Colorectal Tumors
- (2012) Sarah Schwitalla et al. CANCER CELL
- Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway
- (2012) Tz-Ping Wang et al. CARCINOGENESIS
- Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
- (2012) Sarah Schwitalla et al. CELL
- Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine
- (2012) S. Prasad et al. CLINICAL CANCER RESEARCH
- Deguelin, an Akt Inhibitor, Down-Regulates NF-κB Signaling and Induces Apoptosis in Colon Cancer Cells and Inhibits Tumor Growth in Mice
- (2012) Hyoun Woo Kang et al. DIGESTIVE DISEASES AND SCIENCES
- KRAS Mutation and NF-κB Activation Indicates Tolerance of Chemotherapy and Poor Prognosis in Colorectal Cancer
- (2012) Gen Lin et al. DIGESTIVE DISEASES AND SCIENCES
- The NF-κB target genes ICAM-1 and VCAM-1 are differentially regulated during spontaneous differentiation of Caco-2 cells
- (2012) Erhan Astarci et al. FEBS Journal
- NLRP12 Suppresses Colon Inflammation and Tumorigenesis through the Negative Regulation of Noncanonical NF-κB Signaling
- (2012) Irving C. Allen et al. IMMUNITY
- It takes two to tango: IκBs, the multifunctional partners of NF-κB
- (2012) Michael Hinz et al. IMMUNOLOGICAL REVIEWS
- Role of NF-κB in epithelial biology
- (2012) Manolis Pasparakis IMMUNOLOGICAL REVIEWS
- An NF-κB pathway–mediated positive feedback loop amplifies Ras activity to pathological levels in mice
- (2012) Jaroslaw Daniluk et al. JOURNAL OF CLINICAL INVESTIGATION
- Chronic epithelial NF- B activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation
- (2012) H. Shaked et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation and colorectal cancer: colitis-associated neoplasia
- (2012) Sergei I. Grivennikov Seminars in Immunopathology
- Colorectal Cancer Stem Cells
- (2012) Aristides G. Vaiopoulos et al. STEM CELLS
- Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action
- (2012) M. S. I. Abaza et al. TUMOR BIOLOGY
- Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
- (2011) S. I. Grivennikov et al. ANNALS OF THE RHEUMATIC DISEASES
- Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo
- (2011) Yu-Cheng Kuo et al. BIOMEDICINE & PHARMACOTHERAPY
- Multifaceted link between cancer and inflammation
- (2011) Gautam Sethi et al. BIOSCIENCE REPORTS
- Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3
- (2011) Nicolas Porquet et al. BMC CANCER
- A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB
- (2011) Inès Souissi et al. BMC CELL BIOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the inflammatory pathways to enhance chemotherapy of cancer
- (2011) Zhaowei Zhu et al. CANCER BIOLOGY & THERAPY
- Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer
- (2011) Jean-Nicolas Gallant et al. CANCER BIOLOGY & THERAPY
- Gallotannin inhibits NFĸB signaling and growth of human colon cancer xenografts
- (2011) Racha Al-Halabi et al. CANCER BIOLOGY & THERAPY
- Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling
- (2011) Vermont P. Dia et al. CANCER LETTERS
- Notch1 Expression, Which Is Related to p65 Status, Is an Independent Predictor of Prognosis in Colorectal Cancer
- (2011) D. Chu et al. CLINICAL CANCER RESEARCH
- Cytokines, Inflammation and Colon Cancer
- (2011) L. Klampfer CURRENT CANCER DRUG TARGETS
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
- (2011) D. Chen et al. CURRENT CANCER DRUG TARGETS
- Aloe emodin inhibits colon cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB and VEGF via reduced DNA binding activity of NF-κB
- (2011) Priya Suboj et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Boswellic acid inhibits growth and metastasis of human colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogenic biomarkers
- (2011) Vivek R. Yadav et al. INTERNATIONAL JOURNAL OF CANCER
- Intestinal carcinogenesis: IKK can go all the way
- (2011) Yoshiaki Sunami et al. JOURNAL OF CLINICAL INVESTIGATION
- Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice
- (2011) Katerina Vlantis et al. JOURNAL OF CLINICAL INVESTIGATION
- Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation
- (2011) Monica Guma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Colorectal cancer mouse models: Integrating inflammation and the stroma
- (2011) Matthias Ernst et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hierarchies of NF-κB target-gene regulation
- (2011) Stephen T Smale NATURE IMMUNOLOGY
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- BAG-1 interacts with the p50–p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis
- (2011) S L Southern et al. ONCOGENE
- NF- B in Cancer: A Matter of Life and Death
- (2011) B. B. Aggarwal et al. Cancer Discovery
- TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
- (2010) Y Wu et al. BRITISH JOURNAL OF CANCER
- Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer
- (2010) Hyuk-Chan Kwon et al. CANCER SCIENCE
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Suppression of NF-κB and GSK-3β is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone
- (2010) Jung Ok Ban et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inflammation and Colon Cancer
- (2010) Janoš Terzić et al. GASTROENTEROLOGY
- Colon carcinogenesis: Learning from NF-κB and AP-1
- (2010) Aristides G. Vaiopoulos et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma
- (2010) Manish A. Shah et al. INVESTIGATIONAL NEW DRUGS
- L1-Mediated Colon Cancer Cell Metastasis Does Not Require Changes in EMT and Cancer Stem Cell Markers
- (2010) N. Gavert et al. MOLECULAR CANCER RESEARCH
- NF-κB addiction and its role in cancer: ‘one size does not fit all’
- (2010) M M Chaturvedi et al. ONCOGENE
- NF-ĸB and Bcl-3 Activation Are Prognostic in Metastatic Colorectal Cancer
- (2010) Soham D. Puvvada et al. ONCOLOGY
- Induction of oncogene addiction shift to NF-κB by camptothecin in solid tumor cells
- (2009) Tomiteru Togano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Expression of COX-2, NF-κB-p65, NF-κB-p50 and IKKα in malignant and adjacent normal human colorectal tissue
- (2009) M P Charalambous et al. BRITISH JOURNAL OF CANCER
- Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
- (2009) Sander Tas et al. CURRENT GENE THERAPY
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
- (2009) Sergei I. Grivennikov et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis
- (2009) Julia Bollrath et al. EMBO REPORTS
- The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-κB signaling pathway in colorectal carcinomas
- (2009) Yuying Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2
- (2009) Ponnuraj Nagendraprabhu et al. INVESTIGATIONAL NEW DRUGS
- Effectiveness of IκB kinase inhibitors in murine colitis-associated tumorigenesis
- (2009) Yoku Hayakawa et al. JOURNAL OF GASTROENTEROLOGY
- NF-κB and cancer: how intimate is this relationship
- (2009) Sahdeo Prasad et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started